AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 289: F611-F621, 2005. First published May 3, 2005; doi:10.1152/ajprenal.00435.2004
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/3/F611    most recent
00435.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iacobini, C.
Right arrow Articles by Pugliese, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iacobini, C.
Right arrow Articles by Pugliese, G.

Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice

Carla Iacobini,1,2 Giovanna Oddi,1,2 Stefano Menini,2 Lorena Amadio,1,2 Carlo Ricci,2 Clelia Di Pippo,2 Mariella Sorcini,1 Flavia Pricci,1 Francesco Pugliese,2 and Giuseppe Pugliese2

1Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome; and 2Department of Clinical Sciences, "La Sapienza" University, Rome, Italy

Submitted 7 December 2004 ; accepted in final form 22 April 2005

Aging is characterized by renal functional and structural abnormalities resembling those observed in diabetes. These changes have been related to the progressive accumulation of advanced glycation end-products (AGEs) and cumulative oxidative stress occurring in both conditions. We previously reported that galectin-3 ablation is associated with increased susceptibility to diabetes- and AGE-induced glomerulopathy, thus indicating a protective role of galectin-3 as an AGE receptor. To investigate the role of the AGE/AGE receptor pathway in the pathogenesis of age-related renal disease, we evaluated the development of glomerular lesions in aging galectin-3 knockout (KO) vs. wild-type (WT) mice and their relation to the increased AGE levels and oxidative stress characterizing the aging process. KO mice showed significantly more pronounced age-dependent increases in proteinuria, albuminuria, glomerular sclerosis, and glomerular and mesangial areas, starting at 18 mo, as well as renal extracellular matrix mRNA and protein expression, starting at 12 mo vs. age-matched WT mice. Circulating and renal AGEs, plasma isoprostane 8-epi-PGF2{alpha} levels, glomerular content of the glycoxidation and lipoxidation products N{epsilon}-carboxymethyllysine and 4-hydroxy-2-nonenal, and renal nuclear factor-{kappa}B activity also increased more markedly with age in KO than WT mice. AGE levels correlated significantly with renal functional and structural parameters. These data indicate that aging galectin-3 KO mice develop more pronounced changes in renal function and structure than coeval WT mice, in parallel with a more marked degree of AGE accumulation, oxidative stress, and associated low-grade inflammation, thus supporting the concept that the AGE/AGE receptor pathway is implicated in age-related renal disease.

age-related glomerulopathy; advanced glycation end-products; advanced glycation end-product receptors; oxidative stress



Address for reprint requests and other correspondence: G. Pugliese, Dipartimento di Scienze Cliniche (Endocrinologia), Viale del Policlinico, 155–00161 Rome, Italy (e-mail: giuseppe.pugliese{at}uniroma1.it)




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
D. Delacour, A. Koch, W. Ackermann, I. E.-L. Parco, H.-P. Elsasser, F. Poirier, and R. Jacob
Loss of galectin-3 impairs membrane polarisation of mouse enterocytes in vivo
J. Cell Sci., February 15, 2008; 121(4): 458 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Butscheid, P Hauptvogel, P Fritz, U Klotz, and D M Alscher
Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease
J. Clin. Pathol., April 1, 2007; 60(4): 415 - 418.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Menini, L. Amadio, G. Oddi, C. Ricci, C. Pesce, F. Pugliese, M. Giorgio, E. Migliaccio, P. Pelicci, C. Iacobini, et al.
Deletion of p66Shc Longevity Gene Protects Against Experimental Diabetic Glomerulopathy by Preventing Diabetes-Induced Oxidative Stress
Diabetes, June 1, 2006; 55(6): 1642 - 1650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.